KOSPI · Healthcare · ₩40B
₩1,403+1.15%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
6/'26
3/'26 vs prev quarter
Short Volume 5.8% · as of 26.10.28
Among 98 제약 peers
Quarterly Revenue Growth
“매출 회복과 신약 허가 진전이 다음 성장을 준비해요.”
In the company's words · 2026 2분기 filing